Original Research
Published on 22 May 2024
Ketamine modulates disrupted in schizophrenia-1/glycogen synthase kinase-3β interaction
in Molecular Signalling and Pathways
- 1,493 views
- 2 citations
Original Research
Published on 22 May 2024
in Molecular Signalling and Pathways
Original Research
Published on 22 May 2024
in Brain Disease Mechanisms
Original Research
Published on 22 May 2024
in Brain Disease Mechanisms
Original Research
Published on 22 May 2024
in Neuroplasticity and Development
Original Research
Published on 22 May 2024
in Pain Mechanisms and Modulators
Original Research
Published on 21 May 2024
in Brain Disease Mechanisms
Original Research
Published on 17 May 2024
in Brain Disease Mechanisms
Original Research
Published on 17 May 2024
in Brain Disease Mechanisms
Systematic Review
Published on 16 May 2024
in Molecular Signalling and Pathways
Mini Review
Published on 15 May 2024
in Molecular Signalling and Pathways
Original Research
Published on 15 May 2024
in Molecular Signalling and Pathways
Original Research
Published on 15 May 2024
in Neuroplasticity and Development
Original Research
Published on 15 May 2024
in Methods and Model Organisms
Original Research
Published on 14 May 2024
in Brain Disease Mechanisms
Editorial
Published on 14 May 2024
in Brain Disease Mechanisms
Perspective
Published on 14 May 2024
in Neuroplasticity and Development